These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6166806)

  • 1. Studies on the autonomic nervous system with SK&F 92657, a new antihypertensive agent causing direct arterial vasodilatation and beta-adrenoceptor blockade.
    Taylor EM; Eden RJ; Fielden R; Owen DA
    J Cardiovasc Pharmacol; 1981; 3(2):355-68. PubMed ID: 6166806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic profile of a new antihypertensive agent D,L-3-[2-(3-t-butylamino-2-hydroxypropoxy)phenyl]-6-hydrazinopyridazine (SK&F 92657).
    Taylor EM; Cameron D; Eden RJ; Fielden R; Owen DA
    J Cardiovasc Pharmacol; 1981; 3(2):337-54. PubMed ID: 6166805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SK&F 92657, a novel antihypertensive acting by precapillary vasodilatation and beta-adrenoreceptor blockade.
    Taylor EM; Roe AM; Slater RA
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():433s-436s. PubMed ID: 44235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SK & F 95018, a vasodilator/beta-adrenoceptor antagonist.
    Swayne GT; Owen DA; Taylor EM; Eden RJ; Slater RA; Howson W
    Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):251-66. PubMed ID: 2892473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
    Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
    Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
    Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete reversal of beta-adrenoceptor desensitization in human and guinea-pig cardiomyocytes by cyclic nucleotide phosphodiesterase inhibitors.
    Wynne DG; Poole-Wilson PA; Harding SE
    Br J Pharmacol; 1993 Aug; 109(4):1071-8. PubMed ID: 7691363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of a combined arteriolar dilator and beta-adrenoceptor antagonist (SK & F 92657) in the peripheral vessels of man.
    Collier JG; Pitcher DW
    Br J Clin Pharmacol; 1980 Dec; 10(6):567-71. PubMed ID: 6110437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of beta-adrenoceptor blockade in man by prizidilol hydrochloride.
    Pitcher DW; Curry PV; Trounce JR
    Br J Clin Pharmacol; 1982 May; 13(5):711-6. PubMed ID: 6123343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 2-adrenoceptor blocking profile of SK&F 104078: further evidence for receptor subtypes.
    Akers I; Coates J; Drew GM; Sullivan AT
    Br J Pharmacol; 1991 Apr; 102(4):943-9. PubMed ID: 1677300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsinolol: the first beta-adrenoceptor blocker with an associated calcitonin gene-related peptide releasing activity in the heart.
    Chen IJ; Yeh JL; Lo YC; Sheu SH; Lin YT
    Br J Pharmacol; 1996 Sep; 119(1):7-14. PubMed ID: 8872350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological studies with SK&F 93944 (temelastine), a novel histamine H1-receptor antagonist with negligible ability to penetrate the central nervous system.
    Brown EA; Griffiths R; Harvey CA; Owen DA
    Br J Pharmacol; 1986 Mar; 87(3):569-78. PubMed ID: 2879585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eugenodilol: a third-generation beta-adrenoceptor blocker, derived from eugenol, with alpha-adrenoceptor blocking and beta2-adrenoceptor agonist-associated vasorelaxant activities.
    Huang YC; Wu BN; Lin YT; Chen SJ; Chiu CC; Cheng CJ; Chen IJ
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):10-20. PubMed ID: 10413061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenergic receptor responsiveness to isoprenaline in humans: concentration-effect, as compared with dose-effect evaluation and influence of autonomic reflexes.
    Martinsson A; Lindvall K; Melcher A; Hjemdahl P
    Br J Clin Pharmacol; 1989 Jul; 28(1):83-94. PubMed ID: 2550046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trachea relaxing effects and beta2-selectivity of SPFF, a newly developed bronchodilating agent, in guinea pigs and rabbits.
    Gan LL; Wang MW; Cheng MS; Pan L
    Biol Pharm Bull; 2003 Mar; 26(3):323-8. PubMed ID: 12612441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities.
    Chiu CC; Wu JR; Lee CH; Liou SF; Dai ZK; Chen IJ; Yeh JL
    Pharmacology; 2004 Mar; 70(3):140-51. PubMed ID: 14752234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasomolol: an ultra short-acting and vasorelaxant vanilloid type beta 1-adrenoceptor antagonist.
    Lin YT; Wu BN; Wu JR; Lo YC; Chen LC; Chen IJ
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):149-57. PubMed ID: 8797149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist.
    Tesfamariam B; Allen GT
    Br J Pharmacol; 1994 May; 112(1):55-8. PubMed ID: 7913381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of beta-adrenoceptor blocking efficacy of two formulations of esmolol in vivo and in vitro.
    Tripathi CB; Bhattacharya P; Bhatt JD; Hemavathi KG
    Indian J Physiol Pharmacol; 1999 Apr; 43(2):255-8. PubMed ID: 10365322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.